Jonathan P. Mow
2018
In 2018, Jonathan P. Mow earned a total compensation of $595.6K as Chief Executive Officer at PhaseBio Pharmaceuticals, a 37% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $201,300 |
|---|---|
| Option Awards | $34,531 |
| Salary | $358,971 |
| Other | $828 |
| Total | $595,630 |
Mow received $359K in salary, accounting for 60% of the total pay in 2018.
Mow also received $201.3K in non-equity incentive plan, $34.5K in option awards and $828 in other compensation.
Rankings
In 2018, Jonathan P. Mow's compensation ranked 11,305th out of 14,244 executives tracked by ExecPay. In other words, Mow earned more than 20.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,305 out of 14,244 | 21st |
Division Manufacturing | 4,572 out of 5,759 | 21st |
Major group Chemicals And Allied Products | 1,732 out of 2,122 | 18th |
Industry group Drugs | 1,471 out of 1,811 | 19th |
Industry Pharmaceutical Preparations | 1,128 out of 1,385 | 19th |
Source: SEC filing on April 5, 2019.
Mow's colleagues
We found three more compensation records of executives who worked with Jonathan P. Mow at PhaseBio Pharmaceuticals in 2018.